Keystone Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Keystone Financial Planning's BMY Position: Q2 2026 in Review
Keystone Financial Planning reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $158K and leaving 156,768 shares worth $9.03M. The position accounts for 2.33% of the portfolio, ranked #13.
Keystone Financial Planning first reported a position in BMY in Q4 2013 and has held it in 18 quarters since. The position peaked at $9.74M in Q1 2025. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Keystone Financial Planning held 156,768 shares of Bristol-Myers Squibb worth $9.03M as of Q2 2026.
- Keystone Financial Planning sold 2,755 Bristol-Myers Squibb shares in Q2 2026, an estimated $158K.
- Bristol-Myers Squibb made up 2.33% of Keystone Financial Planning's portfolio in Q2 2026, its #13 holding.
- Keystone Financial Planning first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 18 quarters since.
- Keystone Financial Planning's Bristol-Myers Squibb position peaked at $9.74M in Q1 2025.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Keystone Financial Planning's 13F filing for Q2 2026, filed 15 Jul 2026.